PBR Nachrichten

 

Under the terms of the agreement, CASI has obtained global rights to TSK011010 for an upfront payment of 5 million euros and an equity investment of 2 million The post CASI Pharmaceuticals in-licenses rights to novel anti-CD38 monoclonal antibody pr...

As per terms of the deal, twoXAR will apply its AI discovery technology to identify a set of initial candidates to treat lung cancer through novel biological mechanisms The post SK Biopharmaceuticals, twoXAR collaborate to develop treatments for NSC...

DUAKLIR PRESSAIR is a fixed-dose LAMA/LABA combination of the long-acting muscarinic antagonist (LAMA) aclidinium and the long-acting beta agonist (LABA) formoterol. It is administered twice daily via the The post FDA approves DUAKLIR PRESSAIR to tr...

LabCorp said that the proposed deals will make the company to pay a net cash of $485m and will add an incremental $156m to revenues on a pro The post LabCorp to buy Envigo's non-clinical research services business in $485m deal appeared first on Ph...

The research collaboration is part of Atomwise's Artificial Intelligence Molecular Screen (AIMS) Awards program. The Centers for Disease Control and Prevention (CDC) estimates that 6-7 million people in The post DNDi, Atomwise collaborate to advanc...

Hyleukin-7 also received ODD from the European Medicines Agency in 2017, and it is the first and only agent that has obtained ODD for ICL. ICL was first The post FDA grants orphan drug designation to NeoImmuneTech's Hyleukin-7 for idiopathic CD4+ l...

Based in Athens of Greece, Genepharm is involved in the development, manufacturing and out-licensing of high-value generic pharmaceutical products. The company, which owns a wide portfolio of products, The post MS Pharma to acquire European pharmace...

Under the three-year deal, the partnership will use insitro's platform to create disease models for NASH and discover targets that can impact clinical progression and regression of the The post Gilead, insitro collaborate to develop therapies for n...

The company said that it used a priority review voucher to fast track the review of the regulator on brolucizumab in order to make it available to patients The post FDA accepts Novartis’s BLA for brolucizumab for treatment of wet AMD appeared ...

iPSCs can be derived from adult human tissue cells yet share the developmental potentials of embryonic stem cells. Currently Japan has 6 ongoing clinical trials utilizing this technology, The post Allele, SCM Lifescience sign joint research and deve...

The study will enroll approximately eight patients with PH1 under six years of age. The primary endpoint is the percent reduction in urinary oxalate from baseline to six The post Alnylam initiates ILLUMINATE-B phase 3 pediatric study of Lumasiran to...

Paragon Bioservices is a major viral vector development and manufacturing partner for gene therapies. Paragon president and CEO Pete Buzy said: "We are excited to join forces with The post Catalent to buy CDMO Paragon Bioservices for $1.2bn appeared...

The portfolio includes more than 30 generic injectable products. These products will require to be technology transferred and could be launched within the next one to two years. The post Dr. Reddy’s Laboratories announces acquisition of ANDA p...

The intended clinical trial will be a proof-of-concept study combining Novo Nordisk’s semaglutide (GLP-1 analogue) and Gilead’s cilofexor (FXR agonist) and firsocostat (ACC inhibitor) for the treatment of The post Gilead Sciences and Nov...

The investment in AskBio includes an amount of $225m committed by global alternative asset firm TPG Capital and life sciences investment firm Vida Ventures in exchange of a The post AAV gene therapy company AskBio secures $235m investment appeared f...

Balversa is now indicated in the US for the treatment of adult patients having locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration The post Janssen's Balversa gets FDA approval for metastatic bladder canc...

Wockhardt's Decitabine Injection is a generic version of Dacogen, marketed in USA and other countries by Otsuka. Decitabine is used to treat Myelodysplastic syndromes (MDS), a group of The post Wockhardt receives US FDA approval for cancer drug app...

The study will be conducted at the Aflac Cancer & Blood Disorders Center at Children’s Healthcare of Atlanta. “Given the exciting data Emory University researchers presented at the The post Moleculin announces agreement with Emory Univer...

The trial, called DIAMOND, is the first prospective phase 3 trial which is assessing the rapid initiation of a single-tablet regimen (STR) SYMTUZA for the treatment of human The post Janssen’s HIV drug SYMTUZA yields positive results in DIAMON...

The latest approval for Lynparza in Europe is for its use as a monotherapy for adult patients with germline BRCA1/2-mutations (gBRCAm), and who have human epidermal growth factor The post Lynparza secures European approval for type of advanced breas...